CDC Vital Signs: Pharmacy-Based Naloxone Dispensing — United States, 2012–2018

Aug 12, 2019 | Kim Rodgers

The CDC Vital Signs series addresses a single important public health topic each month. This month’s release presents findings on naloxone prescribing in the United States from 2012 to 2018 and county-level naloxone dispensing in 2018. Naloxone is a life-saving medication that can reverse the effects of an opioid overdose.

Key findings of the report:

  • The number of naloxone prescriptions dispensed doubled from 2017 to 2018 – going from about 270,000 to 556,000 prescriptions.
  • Only one naloxone prescription is dispensed for every 70 high-dose opioid prescriptions, a risk factor for overdose.
  • Naloxone prescribing rates were markedly lower among primary care doctors, pain medicine specialists, surgeons, physician assistants, and nurse practitioners. Providers with higher rates of naloxone prescribing per 100 high-dose opioid prescriptions were addiction medicine specialists, psychiatrists, and pediatricians.
  • Most (71%) Medicare prescriptions for naloxone required a copay, compared to 42% for commercial insurance.
  • Naloxone dispensing is 25 times greater in the highest dispensing counties than the lowest dispensing counties.
  • Rural counties were nearly 3 times more likely to be a low dispensing county compared to metropolitan counties.

CDC recommends that healthcare providers consider offering naloxone to all patients at risk for overdose. Some risk factors make patients particularly vulnerable to prescription opioid overdose, including taking high-dose prescription opioids, using benzodiazepines concurrently with opioids, having a history of substance use disorder, misusing prescription opioids, or using illicit drugs (either opioids or potentially contaminated with opioids). HHS guidance and the Surgeon General’s advisory on naloxone reinforce and expand upon the CDC recommendations on when to consider naloxone for overdose prevention.

CDC’s programmatic opioid funding – Overdose Data to Action – provides supports to states and communities to develop and implement innovative and evidence-based strategies to prevent opioid overdose deaths. This includes using data to help target where the need for naloxone might be the greatest. Across the country, overdose protocols are being set up in emergency departments to initiate medication-assisted treatment, make warm hand-offs to treatment services in the community, create connections to harm reduction services, and dispense naloxone. Significant progress has been made, but there are many opportunities to help improve naloxone prescribing and dispensing.


637020799465370000

About Kim Rodgers

Kim Rodgers is the Communications Manager at NACCHO.

More posts by Kim Rodgers

0 Comments

Related Posts

  • National Environmental Public Health Tracking

Linking Exposures and Health Effects to Environmental...

This year, NACCHO piloted a technical assistance program focused on...

Jul 10, 2020 | Tiara Smith

Linking Exposures and Health Effects to Environmental...

2019 Profile Workforce and Finance Capacity final May 2020 Page 1
  • Press Release

NACCHO New Analysis: Changes in Local Health Department...

— Updated data highlight pre-COVID challenges and potential impact of...

Jul 10, 2020 | Andrea Grenadier

NACCHO New Analysis: Changes in Local Health Department...

Cdc badge small
  • Tools & Resources

CDC Report: Temporary Reassignment of Personnel Requests...

CDC recently updated its flexibilities guidance for recipients and applicants...

Jul 09, 2020 | Kim Rodgers

CDC Report: Temporary Reassignment of Personnel Requests...

Jennifer kertanis headshot 24152456360
  • Opportunity

Top Moments From Day Two at NACCHO 360

Welcome to the final day of NACCHO 360! Yesterday NACCHO Chief Executive...

Jul 09, 2020 | Taylarr Lopez

Top Moments From Day Two at NACCHO 360

COVID VC Screenshot
  • COVID-19
  • Tools & Resources
  • Emergency Response
  • Infectious Disease

NACCHO’s COVID-19 Virtual Community Now Available to All...

NACCHO has opened our COVID-19 Virtual Community to all local health department...

Jul 08, 2020 | Kim Rodgers

NACCHO’s COVID-19 Virtual Community Now Available to All...

Sync2020 logos horizontal 1024x304
  • HIV, STI, & Viral Hepatitis

Scholarships Available: SYNChronicity 2020 Conference –...

SYNC 2020, the National Conference for HIV, HCV, STI and LGBTQ Health, is...

Jul 08, 2020 | Julia Zigman

Scholarships Available: SYNChronicity 2020 Conference –...

  • COVID-19
  • HIV, STI, & Viral Hepatitis
  • Research & Reports

Kaiser Family Foundation: Reduction in Sexual and...

The Kaiser Family Foundation released a new issue brief, Potential Impacts of...

Jul 08, 2020 | Julia Zigman

Kaiser Family Foundation: Reduction in Sexual and...

2000px US CDC logo
  • HIV, STI, & Viral Hepatitis

New Recommendations for Hepatitis Vaccination

CDC has released new recommendations for hepatitis A virus (HAV) vaccination,...

Jul 08, 2020 | Julia Zigman

New Recommendations for Hepatitis Vaccination

TAG Logo
  • HIV, STI, & Viral Hepatitis
  • Research & Reports

Treatment Action Group 2020 Pipeline Report Now Available

Treatment Action Group (TAG) recently published their 2020 Pipeline Report, an...

Jul 08, 2020 | Julia Zigman

Treatment Action Group 2020 Pipeline Report Now Available

Back to Top